Journal of Atherosclerosis and Thrombosis · 2018 · 822 citations · 713 references
MedicineCardiologyPharmacotherapyDisease PreventionRisk AssessmentRisk Factor AnalysisAtherosclerotic Cardiovascular Disease PreventionCardiac Risk AssessmentCardiovascular DiseaseCardiovascular RiskLipid ManagementLipid-lowering TherapyAbsolute Risk EstimationAtherosclerosis RiskAtherosclerotic Cardiovascular Disease Risk EstimationAtherosclerotic Disease PreventionAtherosclerotic ProgressionAtherosclerotic Risk AssessmentIncidence RateIncidence Rate Estimation
In the subsections on dyslipidemia in the assessment of risk factors, absolute risk of ASCVD, lipid management targets as well as drug therapy and diet therapy in improving lifestyle habits, we created CQs and performed an SR based on the MINDS method. For our SR, we essentially chose the literature published before the end of 2015.
713
Harmonizing the Metabolic Syndrome
K. G. M. M. Alberti, Robert H. Eckel, Scott M. Grundy et al. · Circulation · 2009 · 14.7K citations · Full text
2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt et al. · Journal of the American College of Cardiology · 2013 · 12.6K citations
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Prediction of Coronary Heart Disease Using Risk Factor Categories
Peter W.F. Wilson, Ralph B. D’Agostino, Daniel Levy et al. · Circulation · 1998 · 9.6K citations
The metabolic syndrome—a new worldwide definition
K. G. M. M. Alberti, Paul Zimmet, Jonathan E. Shaw · The Lancet · 2005 · 9.3K citations